Skip to content
Open access

Hyperphosphorylated tau pathology in patients with epilepsy and dementia - Neuropathological insights from a historical autopsy cohort.

Sep 2026 · Epilepsy Research · Vol 228, pp. 107910 · 0 citations · 38 references
Medicine

TL;DR

Dementia epileptica was associated with increased pTau burden in the epileptogenic hemisphere and time since diagnosis supporting the concept of seizure-induced pTau accumulation, however, pTau is unlikely to be the primary neuropathological link between epilepsy and dementia in the cohort studied given the overall mild pathology and competing diagnoses.

Abstract

Objective

Accumulation of hyperphosphorylated tau (pTau) is a proposed mechanism for dementia associated with epileptic seizures but the evidence directly linking seizures and pTau accumulation remains weak. Here, we aimed at determining the burden of pTau pathology in a historical cohort of epilepsy patients who developed dementia hypothesizing an association between seizure onset zone and pTau accumulation.

Methods

Post-mortem brain tissue was obtained from the Danish Brain Collection comprising autopsies from psychiatric patients that died between 1945 and 1982. Sections from the middle frontal gyrus, thalamus, and medial temporal lobe from both hemispheres were stained for pTau and beta-amyloid and quantified by a blinded assessor. Comparisons were conducted using non-parametric tests.

Results

Thirty-two patients (median age 61.5 years, 59.4% men) were included. pTau pathology was detected in 22 brains (68.8%), with Tau Burden Scores (0-100) ranging from 2 (almost undetectable) to 94 (high load; median 6.5). pTau burden was significantly associated with age at death (Spearman's rho = 0.62, p < 0.001) and duration of epilepsy (Spearman's rho = 0.47, p = 0.02), but not with other clinical variables. Among 11 patients with focal seizures, a significantly higher pTau (p = 0.02) but not a higher beta-amyloid burden (p = 1.0) was observed in the epileptogenic hemisphere. 81.3% of all patients (n = 26) had a competing dementia diagnosis: three patients fulfilled the pathological criteria of Alzheimer's dementia, 13 patients had clinical and/or autoptic diagnosis of vascular dementia.

Significance

In this cohort, dementia epileptica was associated with increased pTau burden in the epileptogenic hemisphere and time since diagnosis supporting the concept of seizure-induced pTau accumulation. However, pTau is unlikely to be the primary neuropathological link between epilepsy and dementia in the cohort studied given the overall mild pathology and competing diagnoses.

Read PDF

Similar papers

Open access Sep 2026

Comparison of amyloid-β, total tau and phospho-tau in clinical AD patients with and without epileptiform EEG patterns.

BACKGROUND Epilepsy is a relevant comorbidity of dementia due to Alzheimer's Disease (AD) and probably directly related to its pathology. We aimed to generate hypotheses how interictal epileptiform discharges (IEDs) may be associated with pathological levels of AD markers from cerebrospinal fluid (CSF). OBJECTIVE To...

Livia Rabea Ott, W. Hermann, Rüdiger Köhling et al. · 0 citations
Open access Aug 2026

An analysis of cerebral amyloid angiopathy based on samples from human brain bank

CAA is not simply an independent cerebrovascular disorder but also serves as a critical synergistic risk factor for Alzheimer’s disease neuropathologic change (ADNC) progression.

Yi-Zhou Zhang, Meng-Yao Ye, Shixiong Mi et al. · 0 citations
Open access Sep 2026

Lewy Body Disease Across Aging: Clinical and Neuropathological Correlates in a Population Brain Bank.

BACKGROUND Lewy body disease (LBD) is defined by neuronal α-synuclein pathology, but how Braak-staged LBD relates to mixed neuropathology and clinical manifestations within a single population-based cohort remains incompletely characterized. This is especially relevant in cohorts enriched for younger individuals, which...

Vitor Ribeiro Paes, Felipe L. Pereira, C. M. Silva et al. · 0 citations
Open access Sep 2026

Human P301L tau expression in mice alters neuronal excitability independent of neurodegeneration

Data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation.

K. Dunton, Hugo Monchal, Brie E Achorn et al. · 0 citations
Review Sep 2026

Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

A practical multi-axis framework comprising clinical phenotype, AD biological context (AD pathology plus co-pathologies and molecular modifiers), network topography (regional patterns) and tempo (rate of clinical and biomarker progression) is proposed to reduce diagnostic mismatches, make cohorts more comparable and su...

L. Grinberg, M. Murray · 0 citations
Open access Sep 2026

Pilot Multimodal Imaging Assessment of Neuropathological Iron Deposition and Molecular PET in Frontotemporal Lobar Degeneration

Background/Objectives: The role of iron in Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) has been debated. However, the effects of iron on protein burden in these diseases remain poorly elucidated. We hypothesized that there is an association between iron deposition and tau and beta-amyloid depo...

Rodolfo Gabriel Gatto, Hossam Youssef, Gökhan Uruk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.